We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Avid Bioservices Inc (CDMO) USD0.001

Sell:$10.99 Buy:$11.01 Change: $0.32 (3.00%)
Prices delayed by at least 15 minutes | Switch to live prices |
Sell:$10.99
Buy:$11.01
Change: $0.32 (3.00%)
Prices delayed by at least 15 minutes | Switch to live prices |
Sell:$10.99
Buy:$11.01
Change: $0.32 (3.00%)
Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Avid Bioservices, Inc. is a dedicated contract development and manufacturing organization (CDMO) focused on development and Current Good Manufacturing Practices (CGMP) manufacturing of biologics. The Company provides a comprehensive range of process development, CGMP clinical and commercial manufacturing services for the biotechnology and biopharmaceutical industries. Its services include CGMP clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing and regulatory submissions support. For early-stage programs the Company provides a variety of process development activities, including cell line development, upstream and downstream development and optimization, analytical methods development, testing and characterization. The scope of its services ranges from standalone process development projects to full development and manufacturing programs through commercialization. Commercial biologics produced by it are distributed to over 90 countries.

Contact details

Address:
14191 MYFORD ROAD
TUSTIN
92780
United States
Telephone:
+1 (714) 5086100
Website:
https://avidbio.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
CDMO
ISIN:
US05368M1062
Market cap:
$668.87 million
Shares in issue:
63.58 million
Sector:
Biotechnology
Exchange:
NASDAQ
Country:
United States
Currency:
US dollar
Indices:
n/a

Key personnel

  • Nicholas Green
    President, Chief Executive Officer, Director
  • Daniel Hart
    Chief Financial Officer
  • Richard Richieri
    Chief Operations Officer
  • Mark Ziebell
    Vice President, General Counsel, Corporate Secretary
  • Oksana Lukash
    Vice President - People
  • Pramthesh Patel
    Vice President - Process Development
  • Matthew Kwietniak
    Chief Commercial Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.